» Articles » PMID: 9616236

In Vivo Assessment of Neovascularization of Liver Metastases Using Perfusion CT

Overview
Journal Br J Radiol
Specialty Radiology
Date 1998 Jun 9
PMID 9616236
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Neovascularization of tumours produces a high microvessel density. Although diagnostic imaging is unable to visualize microvessels directly, it is possible to demonstrate associated changes in tissue perfusion. The aim of this study was to use the quantitative functional information and high spatial resolution of perfusion computed tomography to study neovascularization of hepatic metastases. Perfusion CT was performed in 13 patients with hepatic metastases from various primary tumours. Arterial perfusion was measured in the metastasis; both arterial and portal perfusion were measured in a small rim of liver tissue immediately adjacent to the metastasis. Perfusion measurements were correlated against survival of the patient in nine cases. Arterial perfusion was increased above normal values, both in the metastasis (median: 0.62 ml min-1 ml-1; range: 0.26-3.05 ml min-1 ml-1) and in the adjacent liver (median: 0.51 ml min-1 ml-1; range: 0.14-1.60 ml min-1 ml-1). Portal perfusion of adjacent liver was highly variable (median: 0.30 ml min-1 ml-1; range: 0.05-1.85 ml min-1 ml-1). Arterial perfusion was positively correlated with portal perfusion within liver tissue adjacent to metastases (p < 0.05, r = 0.58), a reversal of the normal situation. Survival of the patient correlated with arterial perfusion within the metastasis (p < 0.05, r = 0.69) but more closely with arterial perfusion in the adjacent liver (p < 0.02, r = 0.78). In conclusion, alterations in perfusion within metastases and adjacent liver are in accordance with the histological features of neovascularization. Perfusion CT offers a method for studying neovascularization in the living patient and offers prognostic information.

Citing Articles

Role of advanced imaging techniques in the evaluation of oncological therapies in patients with colorectal liver metastases.

Caruso M, Stanzione A, Prinster A, Pizzuti L, Brunetti A, Maurea S World J Gastroenterol. 2023; 29(3):521-535.

PMID: 36688023 PMC: 9850941. DOI: 10.3748/wjg.v29.i3.521.


The Role of Computed Tomography Perfusion in Various Focal Liver Lesions.

Gadupudi V, Ramachandran R, Pulivadula Mohanarangam V Cureus. 2023; 14(12):e32420.

PMID: 36644059 PMC: 9833639. DOI: 10.7759/cureus.32420.


Dynamic contrast-enhanced (DCE) imaging: state of the art and applications in whole-body imaging.

Albano D, Bruno F, Agostini A, Angileri S, Benenati M, Bicchierai G Jpn J Radiol. 2021; 40(4):341-366.

PMID: 34951000 DOI: 10.1007/s11604-021-01223-4.


Perfusion imaging of colorectal liver metastases treated with bevacizumab and stereotactic body radiotherapy.

Detsky J, Milot L, Ko Y, Munoz-Schuffenegger P, Chu W, Czarnota G Phys Imaging Radiat Oncol. 2021; 5:9-12.

PMID: 33458362 PMC: 7807608. DOI: 10.1016/j.phro.2018.01.001.


Correlation of C-arm CT acquired parenchymal blood volume (PBV) with 99mTc-macroaggregated albumin (MAA) SPECT/CT for radioembolization work-up.

Weissinger M, Vogel J, Kupferschlager J, Dittmann H, Vega S, Grosse U PLoS One. 2020; 15(12):e0244235.

PMID: 33378338 PMC: 7773241. DOI: 10.1371/journal.pone.0244235.